Company / Current Assets per Share
Seres Therapeutics, Inc. Current Assets per Share History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$5.71
FY2025
5-year range
$1.56 / $5.71
FY2021-FY2025
Trend
+267.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share changed +267% YoY in FY2025, a notable deviation from the 9-year average annual change of +12%.
Based on SEC 10-K filings.
5.71 in FY2025 with a 10-year CAGR of -15.3%.
Improved from $2.12 to $5.71 over the past 3 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +39.1%
- 5-Year CAGR
- +8.3%
- 10-Year CAGR
- -15.3%
Key checks
Key Insights
- In FY2025, current assets per share increased 267.0% year-over-year.
- Peak current assets per share was recorded in FY2015.
- Lowest current assets per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.18 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.71 | +267.0% |
| FY2023 | $1.56 | -26.6% |
| FY2022 | $2.12 | -36.2% |
| FY2021 | $3.32 | -13.4% |
| FY2020 | $3.83 | +56.6% |
| FY2019 | $2.45 | +7.2% |
| FY2018 | $2.28 | -40.6% |
| FY2017 | $3.84 | -24.3% |
| FY2016 | $5.08 | -83.2% |
| FY2015 | $30.13 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 24, 2026